Safety and Efficacy Study of Antioxidants for the Treatment of the Fragile X Syndrome

Key facts

Sponsor

Yolanda de Diego Otero

Principal Investigator

Yolanda de Diego Otero, PhD

IMABIS Foundation. Hospital Carlos Haya. Malaga

Intervention

Ascorbic Acid (Vitamin C) and Alpha-tocopherol (Vitamin E)(dietary_supplement)

Enrollment

30 enrolled

Eligibility

6-18 years · MALE

Timeline

2010 – 2015

Study locations (1)

• Psychiatric Service. Hospital Carlos Haya, Málaga, Malaga, Spain

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Fragile X syndrome

Additional recruiting or active studies for the same condition.

• RECRUITINGNCT07493096
  Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disorders
  Healing Hope International
• RECRUITINGPHASE2NCT07209462
  Study of MRM-3379 in Male Participants With Fragile X Syndrome (BLOOM)
  Mirum Pharmaceuticals, Inc.
• RECRUITINGNANCT06868979
  Optical Imaging in X-linked Disorders.
  Hospices Civils de Lyon
• RECRUITINGNANCT06740162
  Physical Activity and Community EmPOWERment Project
  University of North Carolina, Chapel Hill
• RECRUITINGPHASE2NCT06081348
  Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders
  Holland Bloorview Kids Rehabilitation Hospital
• RECRUITINGNANCT06279858
  Probiotic Intervention for Microbiome Modifications and Clinical Improvements in Fragile X Syndrome
  Specila hospital for cerebral palsy and developmental neurology
• RECRUITINGNANCT06088589
  Speech-in-noise Perception in Autism and Fragile X
  Children's Hospital Medical Center, Cincinnati
• RECRUITINGNANCT06139172
  Web Intervention for Parents of Youth With Genetic Syndromes (WINGS)
  Rush University Medical Center

See all trials for Fragile X syndrome →